HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.

AbstractBACKGROUND:
Retapamulin is a novel pleuromutilin antibacterial developed for topical use.
OBJECTIVE:
To compare the efficacy and safety of retapamulin ointment, 1% (twice daily for 5 days), with sodium fusidate ointment, 2% (3 times daily for 7 days), in impetigo.
METHODS:
A randomized (2:1 retapamulin to sodium fusidate), observer-blinded, noninferiority, phase III study in 519 adult and pediatric (aged > or = 9 months) subjects.
RESULTS:
Retapamulin and sodium fusidate had comparable clinical efficacies (per-protocol population: 99.1 and 94.0%, respectively; difference: 5.1%, 95% confidence interval: 1.1-9.0%, p = 0.003; intent-to-treat population: 94.8 and 90.1%, respectively; difference: 4.7%, 95% confidence interval: -0.4 to 9.7%, p = 0.062). Bacteriological efficacies were similar. Success rates in the small numbers of sodium-fusidate-, methicillin- and mupirocin-resistant Staphylococcus aureus were good for retapamulin (9/9, 8/8 and 6/6, respectively). Both drugs were well tolerated.
CONCLUSION:
Retapamulin is a highly effective and convenient new treatment option for impetigo, with efficacy against isolates resistant to existing therapies.
AuthorsArnold P Oranje, Olivier Chosidow, Sarvajnamurthy Sacchidanand, Gail Todd, Krishan Singh, Nicole Scangarella, Ribhi Shawar, Monique Twynholm, TOC100224 Study Team
JournalDermatology (Basel, Switzerland) (Dermatology) Vol. 215 Issue 4 Pg. 331-40 ( 2007) ISSN: 1421-9832 [Electronic] Switzerland
PMID17911992 (Publication Type: Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Copyright2007 S. Karger AG, Basel
Chemical References
  • Anti-Bacterial Agents
  • Bridged Bicyclo Compounds, Heterocyclic
  • Diterpenes
  • Ointments
  • retapamulin
  • Fusidic Acid
Topics
  • Administration, Topical
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents (administration & dosage)
  • Bridged Bicyclo Compounds, Heterocyclic (administration & dosage)
  • Child
  • Child, Preschool
  • Diterpenes
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Fusidic Acid (administration & dosage)
  • Humans
  • Impetigo (drug therapy, microbiology, pathology)
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Ointments
  • Single-Blind Method
  • Skin (microbiology, pathology)
  • Staphylococcus aureus (isolation & purification)
  • Streptococcus pyogenes (isolation & purification)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: